Best supportive care for the anaemia of myelodysplasia: inclusion of recombinant erythropoietin therapy?

被引：12

作者：

Bowen, DT ^{[1
]}

Hellstrom-Lindberg, E

机构：

[1] Univ Dundee, Ninewells Hosp, Dundee DD1 9SY, Scotland

[2] Huddinge Univ Hosp, Karolinska Inst, Dept Med, Div Haematol, S-14186 Huddinge, Sweden

来源：

LEUKEMIA RESEARCH | 2001年 / 25卷 / 01期

关键词：

D O I：

10.1016/S0145-2126(00)00100-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：19 / 21

页数：3

共 12 条

[1] Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia [J].

Barosi, G ;

Marchetti, M ;

Liberato, NL .

BRITISH JOURNAL OF CANCER, 1998, 78 (06) :781-787

[2] Cast effectiveness, quality-adjusted life-years and supportive care - Recombinant human erythropoietin as a treatment of cancer-associated anaemia [J].

Cremieux, PY ;

Finkelstein, SN ;

Berndt, ER ;

Crawford, J ;

Slavin, MB .

PHARMACOECONOMICS, 1999, 16 (05) :459-472

[3] Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study [J].

Demetri, GD ;

Kris, M ;

Wade, J ;

Degos, L ;

Cella, D .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3412-3425

[4] International scoring system for evaluating prognosis in myelodysplastic syndromes [J].

Greenberg, P ;

Cox, C ;

LeBeau, MM ;

Fenaux, P ;

Morel, P ;

Sanz, G ;

Sanz, M ;

Vallespi, T ;

Hamblin, T ;

Oscier, D ;

Ohyashiki, K ;

Toyama, K ;

Aul, C ;

Mufti, G ;

Bennett, J .

BLOOD, 1997, 89 (06) :2079-2088

[5] Long-term follow-up of 18 patients with myelodysplastic syndromes responding to recombinant erythropoietin treatment [J].

Hast, R ;

Wallvik, J ;

Folin, A ;

Bernell, P ;

Stenke, L .

LEUKEMIA RESEARCH, 2001, 25 (01) :13-18

[6] Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin:: Results from a randomized phase II study and long-term follow-up of 71 patients [J].

Hellström-Lindberg, E ;

Ahlgren, T ;

Beguin, Y ;

Carlsson, M ;

Carneskog, J ;

Dahl, IM ;

Dybedal, I ;

Grimfors, G ;

Kanter-Lewensohn, L ;

Linder, O ;

Luthman, M ;

Löfvenberg, E ;

Nilsson-Ehle, H ;

Samuelsson, J ;

Tangen, JM ;

Winqvist, I ;

Öberg, G ;

Österborg, A ;

Öst, Å .

BLOOD, 1998, 92 (01) :68-75

[7] Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model [J].

HellstromLindberg, E ;

Negrin, R ;

Stein, R ;

Krantz, S ;

Lindberg, G ;

Vardiman, J ;

Ost, A ;

Greenberg, P .

BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) :344-351

[8] EFFICACY OF ERYTHROPOIETIN IN THE MYELODYSPLASTIC SYNDROMES - A METAANALYSIS OF 205 PATIENTS FROM 17 STUDIES [J].

HELLSTROMLINDBERG, E .

BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (01) :67-71

[9] Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin [J].

Mantovani, L ;

Lentini, C ;

Hentschel, B ;

Wickramanayake, PD ;

Loeffler, M ;

Diehl, V ;

Tesch, H .

BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (02) :367-375

[10]

Perrini PR, 1998, BRIT J HAEMATOL, V103, P1070

← 1 2 →